Literature DB >> 31407139

Adult congenital heart disease with pulmonary arterial hypertension: mechanisms and management.

Michail Papamichalis1, Andrew Xanthopoulos1, Panagiotis Papamichalis2, John Skoularigis1, Filippos Triposkiadis3.   

Abstract

Adult congenital heart disease (ACHD) encompasses a range of structural cardiac abnormalities present before birth attributable to abnormal foetal cardiac development. The pulmonary circulation of patients with ACHD and intracardiac or extracardiac defects is often exposed to increased blood flow and occasionally to systemic pressures. Depending on the location and magnitude of the defect as well as the time of surgical correction, the patient with ACHD is at risk of developing pulmonary arterial hypertension (PAH), which dramatically increases morbidity and mortality. It is encouraging that therapies applied in idiopathic PAH and significantly improve outcome are also effective in ACHD-related PAH (ACHD-PAH). This review summarizes the challenges encountered in the diagnosis and management of ACHD-PAH.

Entities:  

Keywords:  Congenital heart disease; Eisenmenger syndrome; Pathophysiology; Pulmonary arterial hypertension; Pulmonary hypertension; Treatment

Mesh:

Year:  2020        PMID: 31407139     DOI: 10.1007/s10741-019-09847-5

Source DB:  PubMed          Journal:  Heart Fail Rev        ISSN: 1382-4147            Impact factor:   4.214


  121 in total

Review 1.  Birth prevalence of congenital heart disease worldwide: a systematic review and meta-analysis.

Authors:  Denise van der Linde; Elisabeth E M Konings; Maarten A Slager; Maarten Witsenburg; Willem A Helbing; Johanna J M Takkenberg; Jolien W Roos-Hesselink
Journal:  J Am Coll Cardiol       Date:  2011-11-15       Impact factor: 24.094

2.  2018 AHA/ACC Guideline for the Management of Adults With Congenital Heart Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.

Authors:  Karen K Stout; Curt J Daniels; Jamil A Aboulhosn; Biykem Bozkurt; Craig S Broberg; Jack M Colman; Stephen R Crumb; Joseph A Dearani; Stephanie Fuller; Michelle Gurvitz; Paul Khairy; Michael J Landzberg; Arwa Saidi; Anne Marie Valente; George F Van Hare
Journal:  J Am Coll Cardiol       Date:  2018-08-16       Impact factor: 24.094

3.  Pulmonary arterial hypertension in congenital heart disease: an epidemiologic perspective from a Dutch registry.

Authors:  M G J Duffels; P M Engelfriet; R M F Berger; R L E van Loon; E Hoendermis; J W J Vriend; E T van der Velde; P Bresser; B J M Mulder
Journal:  Int J Cardiol       Date:  2006-12-19       Impact factor: 4.164

4.  Contemporary prevalence of pulmonary arterial hypertension in adult congenital heart disease following the updated clinical classification.

Authors:  Annelieke C M J van Riel; Mark J Schuuring; Irene D van Hessen; Aielko H Zwinderman; Luc Cozijnsen; Constant L A Reichert; Jan C A Hoorntje; Lodewijk J Wagenaar; Marco C Post; Arie P J van Dijk; Elke S Hoendermis; Barbara J M Mulder; Berto J Bouma
Journal:  Int J Cardiol       Date:  2014-04-16       Impact factor: 4.164

5.  Mortality in pulmonary arterial hypertension due to congenital heart disease: Serial changes improve prognostication.

Authors:  M T U Schuijt; I M Blok; A H Zwinderman; A C M J van Riel; M J Schuuring; R J de Winter; A L Duijnhouwer; A P J van Dijk; B J M Mulder; B J Bouma
Journal:  Int J Cardiol       Date:  2017-06-01       Impact factor: 4.164

6.  Diagnosis of pulmonary hypertension in the congenital heart disease adult population impact on outcomes.

Authors:  Boris S Lowe; Judith Therrien; Raluca Ionescu-Ittu; Louise Pilote; Giuseppe Martucci; Ariane J Marelli
Journal:  J Am Coll Cardiol       Date:  2011-07-26       Impact factor: 24.094

7.  A binational registry of adults with pulmonary arterial hypertension complicating congenital heart disease.

Authors:  G Strange; M Rose; F Kermeen; C O'Donnell; A Keogh; E Kotlyar; L Grigg; A Bullock; P Disney; N Dwyer; H Whitford; D Tanous; C Frampton; R Weintraub; D S Celermajer
Journal:  Intern Med J       Date:  2015-09       Impact factor: 2.048

Review 8.  How to evaluate patients with congenital heart disease-related pulmonary arterial hypertension.

Authors:  Despoina Ntiloudi; Stavros Zanos; Michael A Gatzoulis; Haralambos Karvounis; George Giannakoulas
Journal:  Expert Rev Cardiovasc Ther       Date:  2018-12-06

9.  2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT).

Authors:  Nazzareno Galiè; Marc Humbert; Jean-Luc Vachiery; Simon Gibbs; Irene Lang; Adam Torbicki; Gérald Simonneau; Andrew Peacock; Anton Vonk Noordegraaf; Maurice Beghetti; Ardeschir Ghofrani; Miguel Angel Gomez Sanchez; Georg Hansmann; Walter Klepetko; Patrizio Lancellotti; Marco Matucci; Theresa McDonagh; Luc A Pierard; Pedro T Trindade; Maurizio Zompatori; Marius Hoeper
Journal:  Eur Heart J       Date:  2015-08-29       Impact factor: 29.983

10.  Pulmonary arterial hypertension associated with congenital heart disease: Comparison of clinical and anatomic-pathophysiologic classification.

Authors:  Sheila Ramjug; Nehal Hussain; Judith Hurdman; Catherine Billings; Athanasios Charalampopoulos; Charlie A Elliot; Ian Sabroe; David G Kiely; Robin Condliffe
Journal:  J Heart Lung Transplant       Date:  2016-01-07       Impact factor: 10.247

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.